BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 26670288)

  • 1. Prognostic Impact of Postoperative Complications in 502 Patients With Surgically Resected Esophageal Squamous Cell Carcinoma: A Retrospective Single-institution Study.
    Baba Y; Yoshida N; Shigaki H; Iwatsuki M; Miyamoto Y; Sakamoto Y; Watanabe M; Baba H
    Ann Surg; 2016 Aug; 264(2):305-11. PubMed ID: 26670288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Significance of Postoperative Complications After Curative Resection for Patients With Esophageal Squamous Cell Carcinoma.
    Saeki H; Tsutsumi S; Tajiri H; Yukaya T; Tsutsumi R; Nishimura S; Nakaji Y; Kudou K; Akiyama S; Kasagi Y; Nakanishi R; Nakashima Y; Sugiyama M; Ohgaki K; Sonoda H; Oki E; Maehara Y
    Ann Surg; 2017 Mar; 265(3):527-533. PubMed ID: 28169928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of postoperative complications on survival of patients after minimally invasive esophagectomy for esophageal cancer.
    Li KK; Wang YJ; Liu XH; Tan QY; Jiang YG; Guo W
    Surg Endosc; 2017 Sep; 31(9):3475-3482. PubMed ID: 27924395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma.
    Ning ZH; Zhao W; Li XD; Chen LJ; Xu B; Gu WD; Shao YJ; Xu Y; Huang J; Pei HL; Jiang JT
    Int J Clin Exp Pathol; 2015; 8(6):6881-90. PubMed ID: 26261575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy comparison of Sweet versus Ivor-Lewis esophagectomy in the treatment of middle-lower esophageal squamous cell carcinoma].
    Yang X; Zhan C; Sun F; Chen L; Shi M; Jiang W; Wang Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Sep; 19(9):979-984. PubMed ID: 27680063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Factors of Salvage Esophagectomy for Residual or Recurrent Esophageal Squamous Cell Carcinoma After Definitive Chemoradiotherapy.
    Kiyozumi Y; Yoshida N; Ishimoto T; Yagi T; Koga Y; Uchihara T; Sawayama H; Hiyoshi Y; Iwatsuki M; Baba Y; Miyamoto Y; Watanabe M; Matsuyama T; Oya N; Baba H
    World J Surg; 2018 Sep; 42(9):2887-2893. PubMed ID: 29423738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of body mass index on postoperative complications and long-term survival in patients with esophageal squamous cell cancer.
    Kamachi K; Ozawa S; Hayashi T; Kazuno A; Ito E; Makuuchi H
    Dis Esophagus; 2016 Apr; 29(3):229-35. PubMed ID: 25789403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the 7th edition of the TNM classification in patients with resected esophageal squamous cell carcinoma.
    Wang J; Wu N; Zheng QF; Yan S; Lv C; Li SL; Yang Y
    World J Gastroenterol; 2014 Dec; 20(48):18397-403. PubMed ID: 25561808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of body mass index on surgical outcomes after esophagectomy for patients with esophageal squamous cell carcinoma.
    Hasegawa T; Kubo N; Ohira M; Sakurai K; Toyokawa T; Yamashita Y; Yamazoe S; Kimura K; Nagahara H; Amano R; Shibutani M; Tanaka H; Muguruma K; Ohtani H; Yashiro M; Maeda K; Hirakawa K
    J Gastrointest Surg; 2015 Feb; 19(2):226-33. PubMed ID: 25398407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association of postoperative outcome with fasting plasma glucose and risk factors in esophageal squamous cell carcinoma].
    Duan X; Gong L; Shang X; Jiang H; Tang P; Yu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Sep; 19(9):1004-1008. PubMed ID: 27680068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The survival impact of postoperative complications after curative resection in patients with esophageal squamous cell carcinoma: propensity score-matching analysis.
    Yamamoto M; Shimokawa M; Yoshida D; Yamaguchi S; Ohta M; Egashira A; Ikebe M; Morita M; Toh Y
    J Cancer Res Clin Oncol; 2020 May; 146(5):1351-1360. PubMed ID: 32185488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A high body mass index in esophageal cancer patients is not associated with adverse outcomes following esophagectomy.
    Miao L; Chen H; Xiang J; Zhang Y
    J Cancer Res Clin Oncol; 2015 May; 141(5):941-50. PubMed ID: 25428458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative lymph-node count is associated with survival in patients with resected esophageal squamous cell carcinoma.
    Baba Y; Watanabe M; Shigaki H; Iwagami S; Ishimoto T; Iwatsuki M; Baba H
    Surgery; 2013 Feb; 153(2):234-41. PubMed ID: 22980434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and clinical impact of sarcopenia in esophageal squamous cell carcinoma.
    Harada K; Ida S; Baba Y; Ishimoto T; Kosumi K; Tokunaga R; Izumi D; Ohuchi M; Nakamura K; Kiyozumi Y; Imamura Y; Iwatsuki M; Iwagami S; Miyamoto Y; Sakamoto Y; Yoshida N; Watanabe M; Baba H
    Dis Esophagus; 2016 Aug; 29(6):627-33. PubMed ID: 26123787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of geriatric nutritional risk index on surgical outcomes after esophagectomy in patients with esophageal cancer.
    Kubo N; Sakurai K; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Yashiro M; Ohira M
    Esophagus; 2019 Apr; 16(2):147-154. PubMed ID: 30311102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of 530 esophageal squamous cell carcinoma patients with minimally invasive Ivor Lewis esophagectomy.
    Qi W; Zixiang W; Tianwei Z; Shuai F; Sai Z; Gang S; Ming W
    J Surg Oncol; 2018 Apr; 117(5):957-969. PubMed ID: 29878389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geriatric Nutritional Risk Index as a prognostic factor in patients with esophageal squamous cell carcinoma -retrospective cohort study.
    Yamana I; Takeno S; Shimaoka H; Yamashita K; Yamada T; Shiwaku H; Hashimoto T; Yamashita Y; Hasegawa S
    Int J Surg; 2018 Aug; 56():44-48. PubMed ID: 29602015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative Infectious Complications are Associated with Adverse Oncologic Outcomes in Esophageal Cancer Patients Undergoing Preoperative Chemotherapy.
    Yamashita K; Makino T; Miyata H; Miyazaki Y; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
    Ann Surg Oncol; 2016 Jun; 23(6):2106-14. PubMed ID: 26753750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
    Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KIF-2C expression is correlated with poor prognosis of operable esophageal squamous cell carcinoma male patients.
    Duan H; Zhang X; Wang FX; Cai MY; Ma GW; Yang H; Fu JH; Tan ZH; Fu XY; Ma QL; Wang XY; Lin P
    Oncotarget; 2016 Dec; 7(49):80493-80507. PubMed ID: 27563815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.